Nektar Therapeutics to Announce Financial Results for the Second Quarter on Thursday, August 13, 2026, After Close of U.S.-Based Financial Markets Life Science Investing
Seer Stockholders Vote to Re-Elect All Seven of Seer's Director Nominees at 2026 Annual Meeting Life Science Investing
Corporate Updates - NurExone appoints Mr. David Stolick to the Board of Directors Life Science Investing
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE COMPANY UPDATE & Q2 2026 FINANCIAL RESULTS Life Science Investing
Delcath Systems to Participate at the Canaccord Genuity 46th Annual Growth Conference Life Science Investing
Arcturus Therapeutics to Report Second Quarter Financial Results and Provide Corporate Update on Aug 6, 2026 Life Science Investing
Ocugen to Host Conference Call on Thursday, August 6 at 8:30 A.M. ET to Discuss Business Updates and Second Quarter 2026 Financial Results Life Science Investing
Kymera Therapeutics to Report Second Quarter 2026 Financial Results on August 5, 2026 Life Science Investing
NeuroPace Receives FDA Guidance on PMA Supplement for Indication Expansion into Idiopathic Generalized Epilepsy Medical Device Investing
